BioInformant

Your Global Leader in Stem Cell Market Research

Home » market research » Page 3

Top 10 Cities for Stem Cell Searches on Google

By 1 Comment

Do you know the top 10 cities for stem cell searches on Google? It is an interesting question, because Google searches reflect individual interest in the topic. Furthermore, geographical data reflects hotspots where user interest is the greatest.  Together, this data reflects important market dynamics within particular geographical areas.

In the analysis below, Google search data from 2004 to present is presented. This search was executed September 6, 2015, using the Google Trends tool. See the chart and map below to learn the top ten cities where users are searching online for topics about stem cells.  The numbers shown represent search volumes relative to the highest search level identified, which is always 100. [Read more…]

Mesenchymal Stem Cell (MSC), Regenerative Medicine (RM), and Cell Therapy (CT) Market Research

By Leave a Comment

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, other cell types. MSCs are of intense therapeutic interest, because they represent a population of cells with the potential to treat a range of acute and degenerative diseases. MSCs are advantageous over other stem cells types for a variety of reasons, including that they are immuno-privileged, making them an advantageous cell type for allogenic transplantation. Because of their unique capacity to form structural tissues, MSCs also being explored for use in 3D printing applications. [Read more…]

We Analyzed a Decade of Historical Information on Cord Blood & Cord Tissue Markets (This Is What We Learned)

By Leave a Comment

The cord blood banking market is complex. There are regions experiencing growth and regions experiencing decline. There are extremely successful cord blood banks, and banks that are going out of business or being acquired by the competition.

In addition, there are unique opportunities occurring within the cord blood space that are based on emerging technologies, such as ex vivo expansion of cord blood.

The cord tissue market is also complex, although for different reasons. Today, half of all cord blood banks worldwide offer this service and the number is accelerating. Interestingly, the mesenchymal stem cells (MSCs) contained in cord tissue may have growing opportunities relative to the hematopoietic stem cells (HSCs) contained in cord blood, because MSCs just surpassed HSCs in the scientific literature for the first time in history.

For this reason, BioInformant is offering industry-leading market intelligence for both cord blood and cord tissue markets for the next 14 days only. 

Act by Feb 29, 2016, and you can get two reports for the price of one, a savings of $3,795.

CORD BLOOD + CORD TISSUE PACKAGE:

This is an exclusive offer available only to BioInformant readers, so enter the coupon code “CordBloodCordTissue” during checkout (for either product) and you will automatically receive the other report for free. 

To compete within the global cord blood banking market, you need to be informed about both cord blood and cord tissue markets. This is your opportunity to get a strategic edge.

[Read more…]

Capitalizing on Mesenchymal Stem Cell Applications – Market Size, Segments, & Trends

By Leave a Comment

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, other cell types. MSCs are of intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases.

MSCs are advantageous over other stem cells types for a variety of reasons: they avoid the ethical issues that surround embryonic stem cell research, and repeated studies have found MSCs to be immuno-privileged, which make them an advantageous cell type for allogenic transplantation. MSCs reduce both the risks of rejection and complications of transplantation. Recently, there have been advances in the use of autologous mesenchymal stem cells to regenerate human tissues, including cartilage, meniscus, tendons, bone fractures, and more. [Read more…]

Do You Know Opportunities for Commercializing Stem Cells, by Stem Cell Type?

By 1 Comment

Commonly investigated stem cell types include embryonic stem cells (ESCs), as well as adult stem cell types that include mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), neural stem cells (NSCs), and induced pluripotent stem cells (iPSCs). There are also other less common stem cell types, including dental pulp stem cells (DPSCs), adipose-derived stem cells (ADSCs), and a variety of perinatal stem cell types, including amniotic stem cells, placental stem cells, umbilical cord blood stem cells, and cord tissue stem cells.

Cancer stem cells also exist, giving rise to clonal populations of cells that form tumors or disperse within the body. Each of these stem cell types represents unique opportunities for research product development.

Importantly, literature concerning the biology, characteristics, and applications of stem cells has flourished over the past few decades.

In full-year 2015, there were 25,613 stem cell scientific publications released, and an all-time search returns 259,218 stem cell scientific publications (Pubmed.gov). [Read more…]

BioInformant's World-Class Clients

Shopping cart0
There are no products in the cart!
Continue shopping
0